485
Life-threatening anaphylactoid reaction to amifostine used with concurrent chemoradiotherapy for nasopharyngeal cancer in a patient with dermatomyositis: a case report with literature review.
 a patient with dermatomyositis: Subject; dermatomyositis: Subject.Disorder; Life-threatening anaphylactoid reaction: Effect; amifostine used with concurrent chemoradiotherapy: Treatment; nasopharyngeal cancer: Treatment.Disorder; amifostine: Treatment.Drug; chemoradiotherapy: Treatment.Drug; amifostine: Combination.Drug; chemoradiotherapy: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient with dermatomyositis: Subject; dermatomyositis: Subject.Disorder; Life-threatening anaphylactoid reaction: Effect; amifostine used with concurrent chemoradiotherapy: Treatment; nasopharyngeal cancer: Treatment.Disorder; amifostine: Treatment.Drug; chemoradiotherapy: Treatment.Drug; amifostine: Combination.Drug; chemoradiotherapy: Combination.Drug